Angiotensin II reduces membranous angiotensin-converting enzyme 2 in pressurized human aortic endothelial cells

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 10, Issue 4, 2009, Pages 210-215

  Iizuka, Kenji ^a   Kusunoki, Asami ^a   MacHida, Takuji ^a   Hirafuji, Masahiko ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

ACE2; Angiotensin II; HAECs; Pressure stress

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; MESSENGER RNA; NIFEDIPINE;

AORTA; ARTICLE; ATMOSPHERIC PRESSURE; CELL MEMBRANE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; NIFEDIPINE; PEPTIDYL-DIPEPTIDASE A; RNA, MESSENGER; STRESS, MECHANICAL;

EID: 73349114950     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309343710     Document Type: Article

References (33)

1. Dzau VJ, Bernstein K., Celermajer D. et al. Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. Cardiovasc Drugs Ther 2002 ; 16: 149-160.
2. Mancia G., Giannattasio C., Seravalle G et al. Protective effects of renin-angiotensin blockade beyond blood pressure control. J Hum Hypertens 2009 ;(In press).
3. Hamming I., Cooper ME, Haagmans BL et al. The emerging role of ACE2 in physiology and disease. J Pathol 2007 ; 212: 1-11.
4. Donoghue M., Hsieh F., Baronas E. et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000 ; 87: E1-9.
5. Burrell LM, Johnston CI, Tikellis C., Cooper ME ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol Metab 2004 ; 15: 166-169.
6. Zhang H., Wada J., Hida K. et al. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem 2001 ; 276: 17132-17139.
7. Wiener RS, Cao YX, Hinds A., Ramirez MI, Williams MC Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung. J Cell Biochem 2007 ; 101: 1278-1291.
8. Iizuka K., Machida T., Kawaguchi H., Hirafuji M. Pulsatile mechanical pressure promotes angiotensin-converting enzyme expression in aortic smooth muscle cells. Cardiovasc Drugs Ther 2008 ; 22: 383-390.
9. Iizuka K., Morita N., Murakami T., Kawaguchi H. Nipradilol inhibits atmospheric pressure-induced cell proliferation in human aortic smooth muscle cells. Pharmacol Res 2004 ; 49: 217-225.
10. Oudit GY, Crackower MA, Backx PH, Penninger JM The role of ACE2 in cardiovascular physiology. Trends Cardiovasc Med 2003 ; 13: 93-101.
11. Santos RA, Simoes e Silva AC, Maric C. et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 2003 ; 100: 8258-8263.
12. Santos RA, Ferreira AJ, Simäμes E. Silva AC Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008 ; 93: 519-527.
13. Ribeiro-Oliveira A. Jr, Nogueira AI, Pereira RM et al. The renin-angiotensin system and diabetes: an update. Vasc Health Risk Manag 2008 ; 4: 787-803.
14. Donoghue M., Wakimoto H., Maguire CT et al. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J Mol Cell Cardiol 2003 ; 35: 1043-1053.
15. Zulli A., Burrell LM, Widdop RE et al. Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. J Histochem Cytochem 2006 ; 54: 147-150.
16. Sluimer JC, Gasc JM, Hamming I. et al. Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. J Pathol 2008 ; 215: 273-279.
17. Burrell LM, Risvanis J., Kubota E. et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 2005 ; 26: 369-375.
18. Goulter AB, Goddard MJ, Allen JC, Clark KL ACE2 gene expression is up-regulated in the human failing heart. BMC Med 2004 ; 2: 19-25.
19. Rentzsch B., Todiras M., Iliescu R. et al. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 2008 ; 52: 967-973.
20. Wakahara S., Konoshita T., Mizuno S. et al. Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio. Endocrinology 2007 ; 148: 2453-2457.
21. Tikellis C., Cooper ME, Bialkowski K. et al. Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney Int 2006 ; 70: 34-41.
22. Gallagher PE, Ferrario CM, Tallant EA MAP kinase/ phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. Am J Physiol Cell Physiol 2008 ; 295: C1169-74.
23. Koka V., Huang XR, Chung AC et al. Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. Am J Pathol 2008 ; 172: 1174-1183.
24. Soler MJ, Ye M., Wysocki J. et al. Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan. Am J Physiol Renal Physiol 2009 ; 296: F398-405.
25. Igase M., Kohara K., Nagai T., Miki T., Ferrario CM Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade. Hypertens Res 2008 ; 31: 553-559.
26. Beldent V., Michaud A., Bonnefoy C., Chauvet MT, Corvol P. Cell surface localization of proteolysis of human endothelial angiotensin I-converting enzyme. Effect of the amino-terminal domain in the solubilization process. J Biol Chem 1995 ; 270: 28962-28969.
27. Hooper NM, Karran EH, Turner AJ Membrane protein secretases. Biochem J 1997 ; 321: 265-279.
28. Ramchandran R., Sen I. Cleavage processing of angiotensin-converting enzyme by a membrane-associated metalloprotease. Biochemistry 1995 ; 34: 12645-12652.
29. Rivilis I., Milkiewicz M., Boyd P. et al. Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis. Am J Physiol Heart Circ Physiol 2002 ; 283: H1430-8.
30. Walter A., Etienne-Selloum N., Sarr M. et al. Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols. J Vasc Res 2008 ; 45: 386-394.
31. Encore Investigators. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function). Circulation 2003 ; 107: 422-428.
32. Tomita N., Yamasaki K., Izawa K. et al. Inhibition of experimental abdominal aortic aneurysm progression by nifedipine. Int J Mol Med 2008 ; 21: 239-244.
33. Hirata A., Igarashi M., Yamaguchi H. et al. Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2. Br J Pharmacol 2000 ; 131: 1521-1530.